A guide for healthcare professionals on how to support your patients with genitourinary syndrome of the menopause (GSM)
One of the most consistently identified predictors of impaired sexual health in women is the presence of vaginal symptoms.
Genitourinary syndrome of the menopause (GSM) is a term to describe vulvovaginal and lower urinary tract symptoms related to low oestrogen levels, including dryness, irritation or burning, and urinary frequency and urgency. Unlike many other symptoms of the menopause, symptoms of GSM often worsen over time.
Up to 84% of postmenopausal women have symptoms associated with GSM yet only a minority receive any treatment [1].
This downloadable guidance, written and reviewed by healthcare professionals, is designed to support healthcare professionals in diagnosing and managing this condition, including in those with a history of cancer.
The guidance covers:
- Signs and symptoms
- The impact of GSM
- Useful questions to ask your patient
- Management options, including hormonal and non-hormonal treatments.
